U.S. Employment

Showing 1142 articles

Sanofi Halts mRNA Flu Vaccine Trial Amid Surging U.S. Influenza Season

French pharmaceutical giant Sanofi has discontinued development of its experimental mRNA flu vaccine, citing a strategic reprioritization. The decision comes as influenza activity remains high across much of the United States, with significant hospitalizations and deaths reported this season.